Jove
Visualize
Contáctanos

Videos de Conceptos Relacionados

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

40
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
40
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

22
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
22
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

34
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
34
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

27
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
27
Varicose Veins II: Diagnostic Studies and Interprofessional Care01:26

Varicose Veins II: Diagnostic Studies and Interprofessional Care

31
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
31

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Giant Left Atrial Appendage Aneurysm in an Adolescent: Resection With Patent Foramen Ovale Closure.

World journal for pediatric & congenital heart surgery·2026
Same author

CD24 in Melanoma: Biomarker, Innate Immune Checkpoint and Emerging Therapeutic Target.

Experimental dermatology·2026
Same author

The Secretome of Bullous Pemphigoid IgG-Treated Keratinocytes Induces a Pro-Inflammatory Eosinophil Response.

Experimental dermatology·2026
Same author

Advances in Percutaneous and Endovascular Locoregional Therapies for Primary and Metastatic Lung Cancer.

Cancers·2026
Same author

Abrupt-Onset Pink Scalp Nodules in an Adult: Answer.

The American Journal of dermatopathology·2026
Same author

Abrupt-Onset Pink Scalp Nodules in an Adult.

The American Journal of dermatopathology·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Video Experimental Relacionado

Updated: Sep 9, 2025

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
06:30

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats

Published on: May 23, 2025

331

Desarrollo de tromboflebitis superficial y subsecuente oclusión de la vena central de la retina en un paciente que

Kevin Truong-Balderas1, Maria Mihailescu1, Grace Tu2

  • 1Department of Dermatology, Rush University Medical Center, Chicago, Illinois, USA.

Ocular immunology and inflammation
|August 28, 2025
PubMed
Resumen

El tratamiento intravenoso con inmunoglobulina (IVIg) para la pemphigoid de la membrana mucosa ocular (oMMP) puede conducir a eventos vasculares graves como la oclusión de la vena central de la retina (OCRV). El reconocimiento temprano de la tromboflebitis superficial (STP) durante el IVIg es crucial para prevenir la pérdida de la visión.

Palabras clave:
Oclusión de la vena central de la retinainmunoglobulina por vía intravenosapemphigoides de las membranas mucosasPemphigoides cicatriciales en el ojoTromboflebitis superficial en los niños

Más Videos Relacionados

Intravitreal Injections in the Ovine Eye
03:37

Intravitreal Injections in the Ovine Eye

Published on: July 5, 2022

3.4K
Puncture-Induced Iris Neovascularization as a Mouse Model of Rubeosis Iridis
06:57

Puncture-Induced Iris Neovascularization as a Mouse Model of Rubeosis Iridis

Published on: March 8, 2018

8.9K

Videos de Experimentos Relacionados

Last Updated: Sep 9, 2025

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
06:30

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats

Published on: May 23, 2025

331
Intravitreal Injections in the Ovine Eye
03:37

Intravitreal Injections in the Ovine Eye

Published on: July 5, 2022

3.4K
Puncture-Induced Iris Neovascularization as a Mouse Model of Rubeosis Iridis
06:57

Puncture-Induced Iris Neovascularization as a Mouse Model of Rubeosis Iridis

Published on: March 8, 2018

8.9K

Área de la Ciencia:

  • Oftalmología
  • Inmunología
  • Medicina vascular

Sus antecedentes:

  • El pemphigoide de la membrana mucosa ocular (oMMP) es una enfermedad autoinmune grave que afecta a los ojos.
  • La inmunoglobulina intravenosa (IVIg) es un tratamiento reconocido para la oMMP grave.
  • Las complicaciones tromboembólicas son un riesgo potencial asociado con el tratamiento con IVIg.

Objetivo del estudio:

  • Informar de un caso de oMMP complicado por tromboflebitis superficial (STP) y oclusión de la vena central de la retina (CRVO) durante el tratamiento con IVIg.
  • Para resaltar el posible vínculo entre la terapia IVIg y los eventos tromboembólicos en pacientes con oMMP.

Principales métodos:

  • Un informe de caso observacional que detalle el curso clínico de un paciente con oMMP.
  • Revisión de la historia clínica del paciente, de los hallazgos de laboratorio y de las intervenciones de tratamiento.

Principales resultados:

  • Un varón de 43 años desarrolló STP recurrente y posteriormente experimentó pérdida de visión debido a CRVO no isquémico durante el tratamiento con IVIg.
  • Las pruebas de laboratorio revelaron elevados anticuerpos anti-cardiolipina IgM, lo que indica un estado protrombótico.
  • La modificación del tratamiento, incluida la interrupción del IVIg, la anticoagulación, el rituximab y las inyecciones intravítreas, dio lugar a una recuperación parcial de la visión.

Conclusiones:

  • IVIg, aunque es eficaz para el oMMP, puede elevar el riesgo de eventos tromboembólicos en individuos susceptibles.
  • La STP recurrente durante el tratamiento con IVIg puede ser una señal de alerta temprana de complicaciones vasculares graves como el VRCV.
  • La investigación de la hipercoagulabilidad es esencial para el tratamiento de pacientes con oMMP tratados con IVIg para prevenir la pérdida irreversible de la visión.